The Boston-Cambridge life sciences cluster, reflecting the Greater Boston metropolitan area, is the premier location for the life sciences industry on the U.S. East Coast.
The Houston life sciences cluster benefits from world-class healthcare institutions and research universities as well as a significant depth of talent.
Mexican exports of pharmaceutical products have increased steadily since the COVD-19 pandemic, doubling in volume compared with the five-year average between 2016-2020. The majority of these sales originate from Mexico City.
Montreal’s life sciences cluster benefits from more than 570,000 people working in health services and professional, scientific and technical services.
The New Jersey life sciences cluster is one of the nation’s most mature, with deep, historical presence of the pharmaceutical industry. Almost 83,000 people work in the local industry, the fourth-largest workforce in the U.S.
The New York City life sciences cluster has demonstrated significant growth and momentum over the last several years. Almost 59,000 people work in the industry in New York City proper and its adjacent counties.
The Philadelphia life sciences cluster is one of the most important in the U.S., with a strong, longstanding presence of the big pharma industry, and has also emerged recently as a top center for cell and gene therapy innovation.
The Raleigh-Durham life sciences cluster is one of the most important in the U.S., with a strong, historical presence of the pharmaceutical industry and massive, new investments in biomanufacturing facilities.
San Diego is one of the top three U.S. life sciences clusters. More than 89,000 people work in the local industry, over 17,000 of whom are in life sciences research and development (R&D) roles.
The San Francisco life sciences cluster is the largest on the U.S. West Coast. More than 147,000 people work in the local industry, over 42,000 in life sciences research and development (R&D) roles.
The life sciences cluster stretching across the Washington, D.C.-Baltimore region is one of the most important in the U.S., bolstered by the presence of federal government agencies and world-renown universities.
Barcelona has all the components of a vital life sciences ecosystem: excellent infrastructure, world-renowned hospitals, impressive scientific talent, a well-established business support network and high quality of life that attracts new talent.
The Leiden Bio Science Park is the Netherlands’ main life sciences cluster due to the strong pharma and healthcare presence and close proximity to Amsterdam and Schiphol Airport.
London has all the elements of a strong global life sciences hub, with three of the world's leading universities for biomedical sciences—UCL, King’s College and Imperial College—located within the city.
The Oxford cluster is one of the most established science and innovation ecosystems in Europe. The availability of early-stage and venture capital funding has contributed to its rapid growth over the last several years.
Paris is at the epicenter of the French life sciences cluster, benefitting from an influx of government and private funding to support healthcare initiatives.
Beijing is one of China’s two comprehensive life sciences clusters, alongside Shanghai, that offer a spectrum of research and development (R&D), manufacturing, medical technology and front office or headquarters space.
Melbourne is the leading hub for life sciences in Australia, providing a comprehensive ecosystem of cutting-edge biotechnology, pharmaceuticals, medical research, healthcare innovation and manufacturing.
Singapore is one of the few markets in Asia-Pacific with a full end-to-end value chain—manufacturing, research and development (R&D), sales and logistics.
Greater Tokyo offers Japan’s most comprehensive life sciences industry presence from research and development (R&D) to front office and headquarters locations.